Literature DB >> 35262743

[Catheter ablation of ventricular tachycardia in patients with structural heart disease].

F Lindemann1, A Darma2, G Hindricks2.   

Abstract

Ventricular cardiac rhythm disorders are potentially life-threatening arrhythmias. Ventricular tachycardia (VT) in patients with structural heart disease carries an increased risk of sudden cardiac death. Interventional radiofrequency catheter ablation is increasingly becoming the focus of treatment for ventricular arrhythmias. So far, no randomized study has been able to demonstrate a reduction in mortality; however, depending on the existing cardiomyopathy, interventional VT ablation has proven to be more effective for rhythm stabilization than antiarrhythmic therapy and is subsequently associated with improve quality of life through reduced implantable cardioverter defibrillator (ICD) treatment. The aim of this work is to discuss the pathophysiology, mechanism and treatment of VT with structural heart disease in order to define the role of catheter ablation.
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Ablation techniques; Cardiac arrhythmias; Implantable cardioverter defibrillators; Sudden cardiac death; Ventricular tachycardia

Mesh：

Year:  2022        PMID： 35262743     DOI： 10.1007/s00059-022-05103-z

Source DB:  PubMed          Journal:  Herz        ISSN： 0340-9937            Impact factor:   1.443


  37 in total

1.  Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH).

Authors:  K H Kuck; R Cappato; J Siebels; R Rüppel
Journal:  Circulation       Date:  2000-08-15       Impact factor: 29.690

2.  Association between myocardial substrate, implantable cardioverter defibrillator shocks and mortality in MADIT-CRT.

Authors:  Nitesh Sood; Anne-Christine H Ruwald; Scott Solomon; James P Daubert; Scott McNitt; Bronislava Polonsky; Christian Jons; Christopher A Clyne; Wojciech Zareba; Arthur J Moss
Journal:  Eur Heart J       Date:  2013-10-31       Impact factor: 29.983

3.  [Premature ventricular contractions and tachycardia in a structurally normal heart : Idiopathic PVC and VT].

Authors:  Sonia Busch; Lars Eckardt; Philipp Sommer; Christian Meyer; Hendrik Bonnemeier; Dierk Thomas; Hans-Ruprecht Neuberger; Roland Richard Tilz; Daniel Steven; Christian von Bary; Malte Kuniss; Frederic Voss; Heidi L Estner
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2019-02-14

4.  Long-Term Success of Irrigated Radiofrequency Catheter Ablation of Sustained Ventricular Tachycardia: Post-Approval THERMOCOOL VT Trial.

Authors:  Francis E Marchlinski; Charles I Haffajee; John F Beshai; Timm-Michael L Dickfeld; Mario D Gonzalez; Henry H Hsia; Claudio D Schuger; Karen J Beckman; Frank M Bogun; Scott J Pollak; Anil K Bhandari
Journal:  J Am Coll Cardiol       Date:  2016-02-16       Impact factor: 24.094

5.  Myocardial ischemia and ventricular tachycardia on continuous electrocardiographic monitoring and risk of cardiovascular outcomes after non-ST-segment elevation acute coronary syndrome (from the MERLIN-TIMI 36 Trial).

Authors:  James R Harkness; David A Morrow; Eugene Braunwald; Fang Ren; J Lopez-Sendon; Christopher Bode; Andrzej Budaj; Benjamin M Scirica
Journal:  Am J Cardiol       Date:  2011-09-03       Impact factor: 2.778

6.  Prognostic importance of defibrillator shocks in patients with heart failure.

Authors:  Jeanne E Poole; George W Johnson; Anne S Hellkamp; Jill Anderson; David J Callans; Merritt H Raitt; Ramakota K Reddy; Francis E Marchlinski; Raymond Yee; Thomas Guarnieri; Mario Talajic; David J Wilber; Daniel P Fishbein; Douglas L Packer; Daniel B Mark; Kerry L Lee; Gust H Bardy
Journal:  N Engl J Med       Date:  2008-09-04       Impact factor: 91.245

7.  Ventricular arrhythmia in coronary artery disease: limits of a risk stratification strategy based on the ejection fraction alone and impact of infarct localization.

Authors:  Patrizio Pascale; Jürg Schlaepfer; Mauro Oddo; Marie-Denise Schaller; Pierre Vogt; Martin Fromer
Journal:  Europace       Date:  2009-10-28       Impact factor: 5.214

8.  Catheter ablation of recurrent scar-related ventricular tachycardia using electroanatomical mapping and irrigated ablation technology: results of the prospective multicenter Euro-VT-study.

Authors:  Hildegard Tanner; Gerhard Hindricks; Marius Volkmer; Steve Furniss; Volker Kühlkamp; Dominique Lacroix; Christian DE Chillou; Jesús Almendral; Domenico Caponi; Karl-Heinz Kuck; Hans Kottkamp
Journal:  J Cardiovasc Electrophysiol       Date:  2009-07-28

9.  Catheter ablation of postinfarction ventricular tachycardia: ten-year trends in utilization, in-hospital complications, and in-hospital mortality in the United States.

Authors:  Chandrasekar Palaniswamy; Dhaval Kolte; Prakash Harikrishnan; Sahil Khera; Wilbert S Aronow; Marjan Mujib; William Michael Mellana; Paul Eugenio; Seth Lessner; Aileen Ferrick; Gregg C Fonarow; Ali Ahmed; Howard A Cooper; William H Frishman; Julio A Panza; Sei Iwai
Journal:  Heart Rhythm       Date:  2014-07-09       Impact factor: 6.343

10.  Impact of previous cardiac surgery on long-term outcome of cavotricuspid isthmus-dependent atrial flutter ablation.

Authors:  Paolo D Dallaglio; Ignasi Anguera; Javier Jiménez-Candil; Rafael Peinado; Javier García-Seara; Mari Fe Arcocha; Rosa Macías; Benito Herreros; Aurelio Quesada; Antonio Hernández-Madrid; Miguel Alvarez; Andrea Di Marco; David Filgueiras; Roberto Matía; Angel Cequier; Xavier Sabaté
Journal:  Europace       Date:  2015-10-27       Impact factor: 5.214
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.